RESEARCH PROGRESS ON LONG NON-CODING RNA-MEDIATED SEPSIS PROGRESSION
Keywords:
Long non-coding RNA, Sepsis, Inflammatory response, Immune regulation, Organ injury, Molecular mechanismAbstract
Sepsis represents a severe dysregulation of the host response to infection. In recent years, the involvement of long non-coding RNAs (lncRNAs) in the onset and progression of sepsis has garnered significant attention. This review outlines the expression profiles and regulatory functions of lncRNAs in sepsis, emphasizing their associations with inflammatory processes, immune dysregulation, and organ injury. It highlights the molecular pathways through which lncRNAs influence sepsis by modulating inflammatory signaling, immune cell activities, and programmed cell death. Additionally, the potential utility of lncRNAs as diagnostic markers and therapeutic targets is discussed.References
[1] Cao M, Wang G, Xie J. Immune dysregulation in sepsis: experiences, lessons and perspectives. Cell Death Discovery, 2023, 9(1): 465.
[2] Zhang D, Pei S, Feng Z, et al. Functions and mechanisms of lncRNAs in immune escape and their application in immunotherapy for colorectal cancer. Journal of Translational Medicine, 2025, 23(1): 689.
[3] Zhang Y, Liu H, Niu M, et al. Roles of long noncoding RNAs in human inflammatory diseases. Cell Death Discovery, 2024, 10(1): 235.
[4] Jin L, Liao J, Jin L, et al. Critical role of LncRNA in sepsis-associated acute kidney injury. Frontiers in Pharmacology, 2025, 16: 1627253.
[5] Leng L, Wang H, Hu Y, et al. LINC02363: a potential biomarker for early diagnosis and treatment of sepsis. BMC Immunology, 2025, 26(1): 23.
[6] Ma L, Bajic VB, Zhang Z. On the classification of long non-coding RNAs. RNA Biology, 2013, 10(6): 925-33.
[7] Chodurska B, Kunej T. Long non-coding RNAs in humans: Classification, genomic organization and function. Non-coding RNA Research, 2025, 11: 313-327.
[8] Gao N, Li Y, Li J, et al. Long Non-Coding RNAs: The Regulatory Mechanisms, Research Strategies, and Future Directions in Cancers. Front Oncology, 2020, 10: 598817.
[9] Tang J., Zhang J, Lu Y, et al. Novel insights into the multifaceted roles of m6A-modified LncRNAs in cancers: biological functions and therapeutic applications. Biomarker Research, 2023, 11(1): 42.
[10] Zhang X, Wang W, Zhu W, et al. Mechanisms and Functions of Long Non-Coding RNAs at Multiple Regulatory Levels. International Journal of Molecular Sciences, 2019, 20(22).
[11] Shin JJ, Park J, Shin H, et al. Roles of lncRNAs in NF-κB-Mediated Macrophage Inflammation and Their Implications in the Pathogenesis of Human Diseases. International Journal of Molecular Sciences, 2024. 25(5): 2670.
[12] Zhang W, Li Y, Li G, et al. Identification of lncRNAs in peripheral blood mononuclear cells associated with sepsis immunosuppression based on weighted gene co-expression network analysis. Hereditas, 2025, 162(1): 51.
[13] Wen M, Cai G, Ye J, et al. Single-cell transcriptomics reveals the alteration of peripheral blood mononuclear cells driven by sepsis. Annals of Translational Medicine, 2020, 8(4): 125.
[14] Wang W, Yang N, Wen R, et al. Long Noncoding RNA: Regulatory Mechanisms and Therapeutic Potential in Sepsis. Frontiers in Cellular and Infection Microbiology, 2021, 11: 563126.
[15] Fan XY, Ma ZX, Tang LB, et al. lncRNA NEAT1 mediates LPS-induced pyroptosis of BEAS-2B cells via targeting miR-26a-5p/ROCK1 axis. Kaohsiung Journal of Medical Sciences, 2023, 39(7): 665-674.
[16] Cui H, Xie N, Tan Z, et al. The human long noncoding RNA lnc-IL7R regulates the inflammatory response. European Journal of Immunology, 2014, 44(7): 2085-95.
[17] Sun J, Jin T, Su W, et al. The long non-coding RNA PFI protects against pulmonary fibrosis by interacting with splicing regulator SRSF1. Cell Death & Differentiation, 2021, 28(10): 2916-2930.
[18] Chen T, Lu J, Fan Q. lncRNA TUG1 and kidney diseases. BMC Nephrology, 2025, 26(1): 139.
[19] Sun F, Yuan W, Wu H, et al. LncRNA KCNQ1OT1 attenuates sepsis-induced myocardial injury via regulating miR-192-5p/XIAP axis. Experimental Biology and Medicine, 2020, 245(7): 620-630.
[20] Fang Y, Hu J, Wang Z, et al. LncRNA H19 functions as an Aquaporin 1 competitive endogenous RNA to regulate microRNA-874 expression in LPS sepsis. Biomedicine & Pharmacotherapy, 2018, 105: 1183-1191.
[21] Gan Y, Long J, Zeng Y, et al. lncRNA IL-17RA-1 Attenuates LPS-Induced Sepsis via miR-7847-3p/PRKCG-Mediated MAPK Signaling Pathway. Mediators of Inflammation, 2022, 2022: 9923204.
[22] Feng F, Jiao P, Wang J, et al. Role of Long Noncoding RNAs in the Regulation of Cellular Immune Response and Inflammatory Diseases. Cells, 2022, 11(22): 3642.
[23] Liao Z, Zheng R, Shao G. Mechanisms and application strategies of miRNA-146a regulating inflammation and fibrosis at molecular and cellular levels (Review). International Journal of Molecular Medicine, 2023, 51(1).
[24] Huang G, Zhao X, Bai Y, et al. Regulation of mitochondrial autophagy by lncRNA MALAT1 in sepsis-induced myocardial injury. European Journal of Medical Research, 2024, 29(1): 524.
[25] Li Z, Chao T, Chang K, et al. The long noncoding RNA THRIL regulates TNFα expression through its interaction with hnRNPL. Proceedings of the National Academy of Sciences of the United States of America, 2014, 111(3): 1002-7.
[26] Rapicavoli NA, Qu K, Zhang J, et al. A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeutics. eLife, 2013, 2: e00762.
[27] Atianand MK, Hu W, Satpathy AT, et al. A Long Noncoding RNA lincRNA-EPS Acts as a Transcriptional Brake to Restrain Inflammation. Cell, 2016, 165(7): 1672-1685.
[28] Gupta SC, Awasthee N, Rai V, et al. Long non-coding RNAs and nuclear factor-κB crosstalk in cancer and other human diseases. Biochimica et Biophysica Acta - Reviews on Cancer, 2020, 1873(1): 188316.
[29] Statello L, Guo C, Chen L, et al. Gene regulation by long non-coding RNAs and its biological functions. Nature Reviews Molecular Cell Biology, 2021, 22(2): 96-118.
[30] Gao H, Zhang X, Tang F, et al. Knockdown of lncRNA MEG3 protects against sepsis-induced acute lung injury in mice through miR-93-5p-dependent inhibition of NF-κB signaling pathway. Pathology Research and Practice, 2022, 239: 154142. [3